Effects of 0.005% latanoprost on optic nerve head and peripapillary retinal blood flow

Ophthalmologica

Volumn 213, Issue 6, 1999, Pages 355-359

  Seong, Gong Je ^a,b   Lee, Hyung Keun ^a   Hong, Young Jae ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Blood flow; Latanoprost; Optic nerve head; Peripapillary retina

Indexed keywords

LATANOPROST;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; FLOW MEASUREMENT; HUMAN; HUMAN EXPERIMENT; INTRAOCULAR PRESSURE; MALE; NORMAL HUMAN; OPTIC NERVE; RANDOMIZED CONTROLLED TRIAL; RETINA BLOOD FLOW;

ADULT; BLOOD FLOW VELOCITY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRAOCULAR PRESSURE; LASER-DOPPLER FLOWMETRY; MALE; OPHTHALMIC SOLUTIONS; OPTIC DISK; PROSTAGLANDINS F, SYNTHETIC; REFERENCE VALUES; REGIONAL BLOOD FLOW; REPRODUCIBILITY OF RESULTS; RETINAL VESSELS;

EID: 0032717014     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000027454     Document Type: Article

References (29)

1. Stjernschantz J, Alm A: Latanoprost as a new horizon in the medical management of glaucoma. CurrOpin Ophthalmol 1996;7:11-17.
2. Toris CB, Camras CB, Yablonski ME: Effects of PhXA41, a new prostaglandin F2 alpha analogue, on aqueous humor dynamics in human eyes. Ophthalmology 1993;100:1297-1304.
3. Marcello TN, Anne RB, Brenda EW, Stephen MD: A comparative study of the effects of timolol and latanoprost on blood flow velocity of the retrobulbar vessels. Am J Ophthalmol 1996;122:784-789.
4. Maigaard S, Forman A, Anderson KE: Different responses to prostaglandin F2 alpha in human extra- and intramyometrial arteries. Prostaglandins 1985;30:599-607.
5. Nakayama K, Osol G, Halpern W: Differential contractile responses of pressurized porcine coronary resistance-sized and conductance coronary arteries to acetylcholine, histamine and prostaglandin F2 alpha. Blood Vessels 1989;26: 235-245.
6. 2+ entry blockers inhibit prostaglandin F2 alpha-induced cerebrovascular contractile responses in goats. Eur J Pharmacol 1991;203:33-39.
7. Astin M, Gjotterberg M, Holst A, Selen G, Ressul B, Stjernschantz J: Study of the fundus in phakic and aphakic monkey eyes treated with PhXA41. Invest Ophthalmol Vis Sci 1992;33: 1078.
8. Green K, Paterson CA, Siddiqui A: Ocular blood flow after experimental alkali burns and prostaglandin administration. Arch Ophthalmol 1985;103:569-571.
9. Astin M, Stjernschantz J, Selen G: Role of nitric oxide in PG F2 alpha induced ocular hyperemia. Exp Eye Res 1994;59:401-408.
10. Ehinger B: Adrenergic nerves to the eye and to related structures in man and the cynomolgus monkey. Invest Ophthalmol Vis Sci 1996;5: 42-52.
11. Laties AM: Central retinal artery innervation: Absence of adrenergic innervation to the intraocular branches. Arch Ophthalmol 1967;77: 405-409.
12. Michelson G, Schmauss B, Langhans MJ, Harazny J, Groh MJM: Principle, validity, and reliability of scanning laser Doppler flowmetry. J Glaucoma 1996;5:99-105.
13. Hollo G, van den Berg TJ, Greve EL: Scanning laser Doppler flowmetry in glaucoma. Int Ophthalmol 1996;20:63-70.
14. Zimmerman TJ, Kauffman HE: Timolol: A beta adrenergic blocking agent for the treatment of glaucoma. Arch Ophthalmol 1997;95: 601-609.
15. Gabelt BA, Kauffman PL: Prostaglandin F2 alpha increases uveoscleral outflow in the cynomolgus monkey. Exp Eye Res 1989;49:389-402.
16. Katz IM, Hubbard WA, Getson AJ, Gould AL: Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution. Invest Ophthalmol 1976;15:489-493.
17. Marcello TN, Peter H, Stephen MD, Nicolela MT, Hnik P, Drance SM: Scanning laser Doppler flowmeter study of retinal and optic disk blood flow in glaucomatous patients. Am J Ophthalmol 1996;122:775-783.
18. Phelps CD, Courbet JJ: Migraine and low-tension glaucoma. A case-control study. Invest Ophthalmol Vis Sci 1985;26:1105-1108.
19. Drance SM, Douglas GD, Wilsman K, et al: Response of blood flow to warm and cold in normal and low-tension glaucoma patients. Am J Ophthalmol 1988;105:35-39.
20. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL: Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 1994;17:603-624.
21. Graham SL, Drance SM, Wijsman K, Douglas GR, Mikelberg FS: Ambulatory blood pressure monitoring in glaucoma: The nocturnal dip. Ophthalmology 1995;102:61-69.
22. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC: Hypertension, perfusion pressure, and primary open angle glaucoma: A population-based assessment. Arch Ophthalmol 1995; 113:216-221.
23. Grunwald JE: Effect of topical timolol on the human retinal circulation. Invest Ophthalmol Vis Sci 1986;27:1713-1719.
24. Granwald JE, Delehanty J: Effect of topical carteolol on the normal human retinal circulation. Invest Ophthalmol Vis Sci 1992;33:1853-1856.
25. Granwald JE: Effect of two weeks of timolol maleate treatment on the normal retinal circulation. Invest Ophthalmol Vis Sci 1991;32:39-45.
26. Michelson G, Schmauss B: Two dimensional mapping of the perfusion of the retina and optic nerve head. Br J Ophthalmol 1995;79: 1126-1132.
27. Hoste AM: Reduction of IOP with latanoprost. Ophthalmology 1997;104:895-897.
28. Coleman RA, Smith WL, Narumiya S: International union of pharmacology classification of prostanoid receptors: Properties, distribution and structure of the receptors and their subtypes. Pharmacol Rev 1994;46:205-229.
29. Bito LZ: Prostaglandins: A new approach to glaucoma management with a new, intriguing side effect. Surv Ophthalmol 1997;41(suppl 2): S1-14.